Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Becton Dickinson & Co. recalls BD BBL Sensi Disc Clarithromycin- 15 ug

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
Products
  • BD BBL Sensi Disc Clarithromycin- 15 ug
Where it was sold

Domestic distribution nationwide. International distribution worldwide.

Nationwide

Barcodes
30382902316788
Units affected
2,363,168 total units
About this recall
BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678¿